Marksans Pharma Limited shareholders have overwhelmingly approved all resolutions at the 34th Annual General Meeting held on August 27, 2026. Key approvals include the declaration of a final dividend of ₹0.90 per share and the re-appointment of directors. The voting results, consolidated from remote e-voting and the AGM session, demonstrate strong shareholder confidence in the company’s governance and future plans.
Marksans Pharma Annual General Meeting Results
Marksans Pharma Limited conducted its 34th Annual General Meeting (AGM) on Thursday, August 27, 2026. The meeting, held virtually via video conferencing, saw shareholders actively participate in voting on several crucial resolutions. The consolidated results, encompassing both remote e-voting and e-voting conducted during the AGM, indicate widespread shareholder support for the company’s proposed actions.
Key Resolutions Approved
Resolution 1: Adoption of Financial Statements
The first ordinary resolution involved the adoption of the Audited Standalone & Consolidated Financial Statements for the year ended March 31, 2026, along with the reports of the Board of Directors and Auditors. This resolution was passed with a near-unanimous vote, reflecting shareholder approval of the company’s financial performance.
Resolution 2: Dividend Declaration
Shareholders also approved the declaration of a final dividend of ₹0.90 (90 percent) per equity share, with a face value of Re. 1 each. This ordinary resolution highlights the company’s commitment to returning value to its shareholders.
Resolution 3: Director Re-appointment
The re-appointment of Dr. Sunny Sharma as a director was also passed as an ordinary resolution. Dr. Sharma, who retires by rotation, was eligible and offered himself for re-appointment, receiving shareholder endorsement.
Resolution 4: Re-appointment and Remuneration of Whole-time Director
A special resolution was presented for the re-appointment of Mrs. Sandra Saldanha as a Whole-time Director for a period of three years, effective September 25, 2026, along with the approval of her remuneration. This resolution also garnered significant support from the shareholders.
Voting Details
Throughout the voting process, the Promoter & Promoter Group, Public – Institutions, and Public-Non Institutions categories showed a strong majority in favour of all resolutions. The voting was conducted through remote e-voting from August 24-26, 2026, and during the AGM on August 27, 2026. The consolidated report from the scrutinizer, Mr. Jinesh Dedhia, confirms that all resolutions were passed with the requisite majority.
Source: BSE
